Amgen Inc. has entered into an agreement to terminate its License and Collaboration Agreement with Kyowa Kirin Co., Ltd., effective upon receipt of regulatory approval. This termination of a material partnership may signal a strategic shift in Amgen's collaborative R&D efforts or impact the development trajectory of specific assets within its pipeline.
